Lonza

Health Care Technology / Biotechnology

LONN.SW

CHF 441 2.5

Share price

$ 36 bn

Market Cap

$ 36 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.39x the weighted average for S&P 500

FY2021

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Lonza reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 470 Kt (-858 /-64.6% y-o-y). Also positively, carbon intensity declined to 79 t (-191 /-70.7% y-o-y).

Lonza reported Scope 3 emissions for the the twelve months ending31 December 2021 at 2,452

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2021Q4	470	297	173	2,452	5,935	79
2020Q4	1,328	1,077	251		4,907	271

Lonza

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Lonza's carbon footprint

Company environmental metrics